Le rapport
Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde
19,292 rapports et plus encore
Twist Bioscience secures $120M Series D for biotech innovation
Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
COUR Pharmaceuticals Raises $105M Series A to Transform Biotech
COUR Pharmaceuticals has secured $105M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage immunology company developing nanoparticle-based therapies for celiac disease and autoimmune conditions...
Latigo Biotherapeutics Raises $135M Series A to Transform Biotech
Latigo Biotherapeutics has secured $135M Series A in funding to accelerate growth and innovation in the biotech sector. Pain management company developing non-opioid therapies for chronic pain conditions...
Crystalys Therapeutics Raises $205M Series A to Transform Biotech
Crystalys Therapeutics has secured $205M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage biopharmaceutical company developing next-generation oral URAT1 inhibitor dotinurad for the treatment of ...
Peptilogics Raises $78M Series B2 to Transform Biotech
Peptilogics has secured $78M Series B2 in funding to accelerate growth and innovation in the biotech sector. Peptide therapeutics company developing macrocyclic peptides for challenging drug targets...
Azafaros Raises $146M Series B to Transform Biotech
Azafaros has secured $146M Series B in funding to accelerate growth and innovation in the biotech sector. Specialty pharmaceutical company advancing nizubaglustat for Gaucher disease and Parkinson's disease...
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.